Liquidity & Technicals

Liquidity & Technicals

CNC is highly liquid — a fund can build a $354M position in 5 days at 20% ADV participation, supporting funds up to $7.1B at a 5% portfolio weight. The tape is bullish on a 3–6 month view: the stock has rallied 64% from its March 2026 lows on the Q1 earnings beat, just triggered a golden cross in January 2026, and is trading at the 75th percentile of its 52-week range. The risk: the move has been violent and fast, and mean-reversion risk is elevated after a +30% weekly gain.

Portfolio Implementation Verdict

5-Day Capacity ($M, 20% ADV)

354

Supported AUM at 5% Wt ($B)

7.1

ADV 20d ($M)

286

52-Week Position (%)

74.6

Technical Score (+3 to -3)

3

Price Snapshot

Current Price

$53.69

YTD Return (%)

28.5

1yr Return (%)

-9.4

52w Position (%)

74.6

All-Time High

$97.22

The Critical Chart: Full Price History

Loading...

CNC peaked at $97 in late 2021, then endured a four-year decline to $25 (March 2026) — a 74% drawdown from all-time high. The stock is now above both the 50-day and 200-day SMA for the first time since 2023. The January 30, 2026 golden cross was confirmed by the Q1 earnings beat on April 28. This is an early-stage trend reversal, not a confirmed uptrend — price is still 45% below the all-time high.

Relative Strength vs Benchmark

Loading...

CNC has massively underperformed both the S&P 500 and XLV (Health Care sector ETF) over the past 5 years. From 2021 to early 2026, CNC lost 35% while SPY gained 28% and XLV was flat. The gap widened dramatically in FY2025 (goodwill impairment, Marketplace shock). The recent rally is beginning to narrow the gap, but CNC remains deeply in relative-strength deficit. This is a contrarian setup — the tape is improving from deeply oversold territory.

Momentum Panel

Loading...

RSI has surged from oversold territory (~35 in March) to near-overbought (~68) on the Q1 earnings beat. The speed of the move (from $25 to $54 in under 2 months) suggests short-term pullback risk, but RSI has not yet hit 70 — the classic overbought threshold. MACD histogram turned decisively positive in late April after the earnings catalyst.

Volume and Volatility

No Results

The July 2, 2025 crash (-40.4% on 13.5x average volume) was the defining tape event — the market's immediate reaction to the Q3 2025 results with the $6.7B goodwill impairment and Marketplace volatility disclosure. The April 28, 2026 earnings-driven rally (+13.9%, 2.6x volume) is the most constructive recent signal — institutional buyers stepped in on a fundamental catalyst.

Median daily trading range over 60 days: 1.73%. This is within normal bounds — impact cost for institutional orders is manageable.

Institutional Liquidity Panel

ADV 20d (Shares)

6,597,307

ADV 20d ($M)

286

ADV 60d (Shares)

6,660,461

ADV as % Mkt Cap

1.08
No Results

At 20% ADV participation, a fund can deploy $354M in 5 days — approximately 1.3% of market cap. This supports funds up to $7.1B at a 5% position weight. At the more conservative 10% ADV participation, $177M clears in 5 days. Liquidity is not a constraint for any fund under $7B. Execution friction (1.73% median daily range) is within normal bounds.

Technical Scorecard and Stance

No Results

Technical stance: Bullish on a 3–6 month horizon. Score: +3 out of +6. The trend has reversed (golden cross confirmed), momentum is strong, and institutional volume supports the move. The primary risk is the speed of the rally — a pullback to the $42–45 range (near the 200-day SMA) would be healthy consolidation, not a trend break. Two levels to watch: above $64 (52-week high breakout) confirms the bull case and targets the $75–80 range; below $38 (prior resistance now support) invalidates the reversal and signals the margin-recovery story is failing. Liquidity is not the constraint — the correct action for an interested fund is to build now on pullbacks rather than chase the momentum.